Cargando…
Cigarette smoke-induced LKB1/AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLC
Smoker patients with non-small cell lung cancer (NSCLC) have poorer prognosis and survival than those without smoking history. However, the mechanisms underlying the low response rate of those patients to EGFR tyrosine kinase inhibitors (TKIs) are not well understood. Here we report that exposure to...
Autores principales: | Cheng, Fang-Ju, Chen, Chia-Hung, Tsai, Wen-Chen, Wang, Bo-Wei, Yu, Meng-Chieh, Hsia, Te-Chun, Wei, Ya-Ling, Hsiao, Yu-Chun, Hu, Dai-Wei, Ho, Chien-Yi, Li, Tzong-Shiun, Wu, Chun-Yi, Chou, Wen-Yu, Yu, Yung-Luen, Tang, Chih-Hsin, Chen, Chih-Yi, Chen, Chuan-Mu, Hsu, Jennifer L., Chen, Hsiao-Fan, Chen, Yeh, Tu, Chih-Yen, Hung, Mien-Chie, Huang, Wei-Chien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878190/ https://www.ncbi.nlm.nih.gov/pubmed/33335306 http://dx.doi.org/10.1038/s41388-020-01597-1 |
Ejemplares similares
-
PKCδ-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs
por: Chen, Chia-Hung, et al.
Publicado: (2021) -
The Feasibility of Interventional Pulmonology Methods for Detecting the T790M Mutation after the First or Second-Generation EGFR-TKI Resistance of Non-Small Cell Lung Cancer
por: Cheng, Wen-Chien, et al.
Publicado: (2022) -
The Impact of Acquired EGFR T790M Mutation and EGFR Circulating Cell-Free DNA on Survival in Patients with Lung Adenocarcinoma Following EGFR-TKI Therapy
por: Cheng, Wen-Chien, et al.
Publicado: (2021) -
Prognostic Value of Tumor Size in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer
por: Chen, Chih-Yu, et al.
Publicado: (2020) -
The optimal therapy strategy for epidermal growth factor receptor‐mutated non‐small cell lung cancer patients with brain metastasis: A real‐world study from Taiwan
por: Cheng, Wen‐Chien, et al.
Publicado: (2022)